Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry

NCT04559009 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT04559009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04559009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry
Lead sponsor
Wake Forest University Health Sciences
Phase
Observational
Overall status
Completed
Start date
October 15, 2020
Completion date
January 31, 2023
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis, covid19